Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | Pomoč | SLO | ENG

Naslov:Melanoma antigens in pediatric medulloblastoma contribute to tumor heterogeneity and species-specificity of group 3 tumors
Avtorji:ID Collins, Rebecca R. J. (Avtor)
ID Florke Gee, Rebecca R. (Avtor)
ID Tozandehjani, Sima (Avtor)
ID Bayat, Tara (Avtor)
ID Hoyos Sanchez, Maria Camila (Avtor)
ID Solano Gutierrez, Juan Sebastian (Avtor)
ID Breznik, Barbara (Avtor)
ID Lee, Anna K. (Avtor)
ID Fon Tacer, Klementina (Avtor)
Datoteke:URL URL - Izvorni URL, za dostop obiščite https://actaneurocomms.biomedcentral.com/articles/10.1186/s40478-025-02055-3
 
.pdf PDF - Predstavitvena datoteka, prenos (5,57 MB)
MD5: DEA9F156024CEBD10AA4816873FE4C79
 
Jezik:Angleški jezik
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:Logo NIB - Nacionalni inštitut za biologijo
Povzetek:Medulloblastoma (MB) is the most malignant childhood brain cancer. Group 3 MB (G3 MB) subtype accounts for about 25% of MB and is associated with the worst outcomes. Herein, we report that more than half of G3 MB tumors express melanoma antigens (MAGEs), which are potential prognostic and therapeutic markers. MAGEs are cancer‑testis antigens, aberrantly expressed in several adult cancers, and associated with poorer prognosis and therapy resistance; however, their role in pediatric cancers is mostly unknown. This study aimed to determine whether MAGEs are activated and important in pediatric MB. We obtained formalin‑fixed paraffin‑embedded tumor samples of 34 patients, collected between 2008 and 2015 at the Children’s Medical Center in Dallas and applied our validated reverse transcription quantitative PCR (RT‑qPCR) assay to measure the expression of 23 MAGE genes. To validate our data, we analyzed published datasets from pediatric MB tumors and patient‑derived orthotopic xenografts, totaling 949 patients. Our RT‑qPCR analysis suggested that MAGEs were expressed in G3/4MB. Further mining of bulk and single‑cell RNA‑sequencing datasets confirmed that 50–75% of G3 tumors activate several MAGEs. Intriguingly, single‑cell data analysis showed that MAGEs are expressed in distinct subsets of cells in MAGE‑positive tumors and are not activated in mouse genetic models, suggesting they contribute to the tumor heterogeneity and species‑specificity of G3 MB. We then examined how MAGE expression affects the growth and oncogenic potential by CRISPR‑Cas9‑ and siRNA‑mediated gene depletion. Depletion of MAGEAs, ‑B2, and ‑Cs altered cell survival, viability, and clonogenic growth due to decreased proliferation and increased apoptosis of MAGE‑positive MB cells. These findings suggested that targeting MAGEs could represent a viable therapeutic strategy for G3 MB. A deeper understanding of MAGE regulation and function is warranted and could aid in improving prognostic and therapeutic approaches for this poorly characterized subgroup of pediatric brain tumors.
Ključne besede:medulloblastoma, tumor antigens, MAGE, pediatric cancer, cancer‑testis antigens
Status publikacije:Objavljeno
Verzija publikacije:Objavljena publikacija
Datum objave:28.07.2025
Leto izida:2025
Št. strani:str. 1-16
Številčenje:Vol. 13, [article no.] 164
PID:20.500.12556/DiRROS-23650 Novo okno
UDK:577.2
ISSN pri članku:2051-5960
DOI:10.1186/s40478-025-02055-3 Novo okno
COBISS.SI-ID:244648963 Novo okno
Opomba:Nasl. z nasl. zaslona; Opis vira z dne 1. 8. 2025; Soavtorji: Rebecca R. Florke Gee, Sima Tozandehjani, Tara Bayat, Maria Camila Hoyos Sanchez, Juan Sebastian Solano Gutierrez, Barbara Breznik, Anna K. Lee, Samuel T. Peters, Jon P. Connelly, Shondra M. Pruett-Miller, Martine F. Roussel, Dinesh Rakheja, Heather S. Tillman, Patrick Ryan Potts & Klementina Fon Tacer;
Datum objave v DiRROS:19.09.2025
Število ogledov:315
Število prenosov:146
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
  
Objavi na:Bookmark and Share


Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:Acta neuropathologica communications
Skrajšan naslov:Acta Neuropathol. Commun.
Založnik:BioMed Central
ISSN:2051-5960
COBISS.SI-ID:522939929 Novo okno

Gradivo je financirano iz projekta

Financer:ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Številka projekta:P1-0245-2019
Naslov:Ekotoksiologija, toksikološka genomika in karcinogeneza

Financer:ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Številka projekta:J3-4504-2022
Naslov:Z vizualizacijo mikrookolja glioblastoma do boljše terapije

Financer:ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Številka projekta:BI-US/22-24-007-2022
Naslov:Vloga proteinov MAGE v glioblastomskih matičnih celicah in odpornosti na terapijo: ali nam lahko znanje o biologiji matičnih celicah pomaga zdraviti na terapijo odporne možganske tumorje?

Financer:ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Številka projekta:BI-US/24-26-022-2024
Naslov:Izkoriščanje proteinov MAGE za boj proti odpornosti agresivnih tumorjev na zdravljenje

Financer:EC - European Commission
Program financ.:HE
Številka projekta:101079113
Naslov:TWINNING FOR EXCELLENCE TO STRATEGICALLY ADVANCE RESEARCH IN CARCINOGENESIS AND CANCER
Akronim:CutCancer

Financer:National Institutes of Health National Cancer Institute
Številka projekta:T32CA136515, CA096832 and CA21765

Financer:American Cancer Society Research Scholar Award
Številka projekta:181691010

Financer:Cancer Prevention and Research Institute of Texas
Številka projekta:R1117, RR200059

Financer:Texas Tech University start-up and the Texas Center for Comparative Cancer Research
Številka projekta:TC3R

Financer:Foundation for Prader–Willi Syndrome Research Grants
Številka projekta:22-0321 and 23-0447

Financer:Fulbright fellowship; John Lawrence and Patsy Louise Goforth Distinguished Chair in Pathology endowment; American Lebanese Syrian Associated Charities of St Jude Children’s Research Hospital

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:meduloblastom, otroški možganski tumorji, MAGE, heterogenost, terapevtske tarče


Nazaj